PROTEINAUFREINIGUNG

European patent · EP2598514 · In force

Register entry

Publication number
EP2598514
Application number
EP11736364
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 26, 2011
Published
Jun 5, 2013
Granted
Sep 9, 2020
Protection ends at the latest
Jul 25, 2031
Next annual fee due
Jul 31, 2027
IPC classes
C07K 1/18 (2006.01)
C07K 1/36 (2006.01)
C07K 16/24 (2006.01)
Priority
GB 201012603 27.07.2010
PCT application
PCT/EP2011/062837 26.07.2011
PCT publication
WO2012/013682 02.02.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Sep 9, 2020

    Granted

    Published in Swissreg on 09.09.2020

Parties

Holder

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventor

SYMMONS, Jonathan

Berkshire SL1 3WE, GB

WHITCOMBE, Richard

Berkshire SL1 3WE, GB

SPITALI, Mariangela

Berkshire SL1 3WE, GB

PEARCE-HIGGINS, Mark Robert

Berkshire SL1 3WE, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.